{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:42:33Z","timestamp":1782895353343,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T00:00:00Z","timestamp":1412208000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s13045-014-0072-6","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T18:38:21Z","timestamp":1412188701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["T cell immune abnormalities in immune thrombocytopenia"],"prefix":"10.1186","volume":"7","author":[{"given":"Xuebin","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,2]]},"reference":[{"key":"72_CR1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-0037-1616570","volume":"93","author":"B Olsson","year":"2005","unstructured":"Olsson B, Andersson PO, Jacobsson S, Carlsson L, Wadenvik A: Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura. Thromb Haemost. 2005, 93: 139-144.","journal-title":"Thromb Haemost"},{"key":"72_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1538-7836.2007.02804.x","volume":"6","author":"XL Zhang","year":"2008","unstructured":"Zhang XL, Peng J, Sun JZ, Guo CS, Yu Y, Wang ZG, Chu XX, Hou M: Modulation of immune response with cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin-induced anergic T cells in chronic idiopathic thrombocytopenic purpura. J Thromb Haemost. 2008, 6: 158-165. 10.1111\/j.1538-7836.2007.02804.x.","journal-title":"J Thromb Haemost"},{"key":"72_CR3","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1182\/blood-2008-03-148288","volume":"113","author":"XL Zhang","year":"2009","unstructured":"Zhang XL, Peng J, Sun JZ, Liu JJ, Guo CS, Wang ZG, Yu Y, Shi Y, Qin P, Li SG, Zhang LN, Hou M: De novo induction of platelet-specific CD4(+) CD25(+) regulatory T cells from CD4(+) CD25(\u2212) cells in patients with idiopathic thrombocytopenic purpura. Blood. 2009, 113: 2568-2577. 10.1182\/blood-2008-03-148288.","journal-title":"Blood"},{"key":"72_CR4","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1182\/blood-2012-02-413526","volume":"120","author":"R Aslam","year":"2012","unstructured":"Aslam R, Hu Y, Gebremeskel S, Segel GB, Speck ER, Guo L, Kim M, Ni H, Freedman J, Semple JW: Thymic retention of CD4 + CD25 + FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia. Blood. 2012, 120: 2127-2132. 10.1182\/blood-2012-02-413526.","journal-title":"Blood"},{"key":"72_CR5","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/j.thromres.2011.07.012","volume":"128","author":"NN Shan","year":"2011","unstructured":"Shan NN, Ji XB, Wang X, Li Y, Liu X, Zhu XJ, Hou M: In vitro recovery of Th1\/Th2 balance in PBMCs from patients with immune thrombocytopenia through the actions of IL-18BPa\/Fc. Thromb Res. 2011, 128: e119-e124. 10.1016\/j.thromres.2011.07.012.","journal-title":"Thromb Res"},{"key":"72_CR6","first-page":"914","volume":"90","author":"T Wang","year":"2005","unstructured":"Wang T, Zhao H, Ren H, Guo J, Xu M, Yang R, Han ZC: Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica. 2005, 90: 914-923.","journal-title":"Haematologica"},{"key":"72_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1365-2141.2007.06737.x","volume":"139","author":"S Li","year":"2007","unstructured":"Li S, Wang L, Zhao C, Li L, Peng J, Hou M: CD8+ T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura. Br J Haematol. 2007, 139: 605-611. 10.1111\/j.1365-2141.2007.06737.x.","journal-title":"Br J Haematol"},{"key":"72_CR8","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1182\/blood-2010-02-267435","volume":"116","author":"L Yang","year":"2010","unstructured":"Yang L, Wang L, Zhao CH, Zhu XJ, Hou Y, Peng J, Hou M: Contributions of TRAIL mediated megakaryocyte apoptosis to impaired megakaryocyte and platelet production in immune thrombocytopenia. Blood. 2010, 116: 4307-4316. 10.1182\/blood-2010-02-267435.","journal-title":"Blood"},{"key":"72_CR9","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1182\/blood-2002-06-1666","volume":"101","author":"J Peng","year":"2003","unstructured":"Peng J, Liu C, Liu D, Ren C, Li W, Wang Z, Xing N, Xu C, Chen X, Ji C, Zhang M, Hou M: Effects of B7-blocking agent and\/or CsA on induction of platelet-specific T-cell anergy in chronic autoimmune thrombocytopenic purpura. Blood. 2003, 101: 2721-2726. 10.1182\/blood-2002-06-1666.","journal-title":"Blood"},{"key":"72_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1084\/jem.192.5.681","volume":"192","author":"JR Abrams","year":"2000","unstructured":"Abrams JR, Kelley SL, Hayes E, Kikuchi T, Brown MJ, Kang S, Lebwohl MG, Guzzo CA, Jegasothy BV, Linsley PS, Krueger JG: Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med. 2000, 192: 681-694. 10.1084\/jem.192.5.681.","journal-title":"J Exp Med"},{"key":"72_CR11","doi-asserted-by":"publisher","first-page":"11902","DOI":"10.1073\/pnas.172277399","volume":"99","author":"K Kokame","year":"2002","unstructured":"Kokame K, Matsumoto M, Soejima K, Yagi H, Ishizashi H, Funato M, Tamai H, Konno M, Kamide K, Kawano Y, Miyata T, Fujimura Y: Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Natl Acad Sci U S A. 2002, 99: 11902-11907. 10.1073\/pnas.172277399.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"72_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbrc.2003.11.111","volume":"313","author":"M Suzuki","year":"2004","unstructured":"Suzuki M, Murata M, Matsubara Y, Uchida T, Ishihara H, Shibano T, Ashida S, Soejima K, Okada Y, Ikeda Y: Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets. Biochem Biophys Res Commun. 2004, 313: 212-216. 10.1016\/j.bbrc.2003.11.111.","journal-title":"Biochem Biophys Res Commun"},{"key":"72_CR13","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.bbrc.2012.01.092","volume":"418","author":"Y Machino","year":"2012","unstructured":"Machino Y, Suzuki E, Higurashi S, Ohta H, Suzuki M, Kohroki J, Masuho Y: Chemically dimerized intravenous immunoglobulin has potent amelioratingactivity in a mouse immune thrombocytopenic purpura model. Biochem Biophys Res Commun. 2012, 418: 748-753. 10.1016\/j.bbrc.2012.01.092.","journal-title":"Biochem Biophys Res Commun"},{"key":"72_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2407-3-21","volume":"3","author":"OF Bathe","year":"2003","unstructured":"Bathe OF, Dalyot-Herman N, Malek TR: Therapeutic limitations in tumor-specific CD8+ memory T cell engraftment. BMC Cancer. 2003, 3: 21-10.1186\/1471-2407-3-21.","journal-title":"BMC Cancer"},{"key":"72_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbrc.2013.05.058","volume":"436","author":"Y Yao","year":"2013","unstructured":"Yao Y, Chen L, Wei W, Deng X, Ma L, Hao S: Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunities. Biochem Biophys Res Commun. 2013, 436: 60-65. 10.1016\/j.bbrc.2013.05.058.","journal-title":"Biochem Biophys Res Commun"},{"key":"72_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1471-2407-13-143","volume":"13","author":"Y Choi","year":"2013","unstructured":"Choi Y, Lee HW, Lee J, Jeon YH: The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131. BMC Cancer. 2013, 13: 143-10.1186\/1471-2407-13-143.","journal-title":"BMC Cancer"},{"key":"72_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/0006-291X(83)91758-8","volume":"113","author":"M Rola-Pleszczynski","year":"1983","unstructured":"Rola-Pleszczynski M, Gagnon L, Sirois P: Leukotriene B4 augments human natural cytotoxic cell activity. Biochem Biophys Res Commun. 1983, 113: 531-537. 10.1016\/0006-291X(83)91758-8.","journal-title":"Biochem Biophys Res Commun"},{"key":"72_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bbrc.2009.04.134","volume":"384","author":"S Zhang","year":"2009","unstructured":"Zhang S, Zhang H, Zhao J: The role of CD4 T cell help for CD8 CTL activation. Biochem Biophys Res Commun. 2009, 384: 405-408. 10.1016\/j.bbrc.2009.04.134.","journal-title":"Biochem Biophys Res Commun"},{"key":"72_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bbrc.2007.12.149","volume":"367","author":"Z Ye","year":"2008","unstructured":"Ye Z, Ahmed KA, Huang J, Xie Y, Munegowda MA, Xiang J: T cell precursor frequency differentially affects CTL responses under different immune conditions. Biochem Biophys Res Commun. 2008, 367: 427-434. 10.1016\/j.bbrc.2007.12.149.","journal-title":"Biochem Biophys Res Commun"},{"key":"72_CR20","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3324\/haematol.12889.","volume":"93","author":"C Zhao","year":"2008","unstructured":"Zhao C, Li X, Zhang F, Wang L, Peng J, Hou M: Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies. Haematologica. 2008, 93: 1428-1430. 10.3324\/haematol.12889..","journal-title":"Haematologica"},{"key":"72_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1600-0609.2005.00622.x","volume":"76","author":"F Zhang","year":"2006","unstructured":"Zhang F, Chu X, Wang L, Zhu Y, Li L, Ma D, Peng J, Hou M: Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura. Eur J Haematol. 2006, 76: 427-431. 10.1111\/j.1600-0609.2005.00622.x.","journal-title":"Eur J Haematol"},{"key":"72_CR22","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00109-007-0235-9","volume":"85","author":"A Zhang","year":"2007","unstructured":"Zhang A, Qu Y, Zhang B, Zhang L, Zeng C, Peng J, Ji X, Hou M, Zhao Y: The different effects of indirubin on effector and CD4 + CD25+ regulatory T cells in mice: potential implication for the treatment of autoimmune diseases. J Mol Med. 2007, 85: 1263-1270. 10.1007\/s00109-007-0235-9.","journal-title":"J Mol Med"},{"key":"72_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imm.12076","volume":"139","author":"N Malhotra","year":"2013","unstructured":"Malhotra N, Kang J: SMAD regulatory networks construct a balanced immune system. Immunology. 2013, 139: 1-10. 10.1111\/imm.12076.","journal-title":"Immunology"},{"key":"72_CR24","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.bbrc.2009.08.062","volume":"388","author":"H Kumar","year":"2009","unstructured":"Kumar H, Kawai T, Akira S: Toll-like receptors and innate immunity. Biochem Biophys Res Commun. 2009, 388: 621-625. 10.1016\/j.bbrc.2009.08.062.","journal-title":"Biochem Biophys Res Commun"},{"key":"72_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bbrc.2007.01.157","volume":"355","author":"M Takei","year":"2007","unstructured":"Takei M, Umeyama A, Arihara S: Diterpenes inhibit IL-12 production by DC and enhance Th2 cells polarization. Biochem Biophys Res Commun. 2007, 355: 603-610. 10.1016\/j.bbrc.2007.01.157.","journal-title":"Biochem Biophys Res Commun"},{"key":"72_CR26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.bbrc.2009.03.101","volume":"382","author":"T Tamachi","year":"2009","unstructured":"Tamachi T, Takatori H, Fujiwara M, Hirose K, Maezawa Y, Kagami S, Suto A, Watanabe N, Iwamoto I, Nakajima H: STAT6 inhibits T-bet-independent Th1 cell differentiation. Biochem Biophys Res Commun. 2009, 382: 751-755. 10.1016\/j.bbrc.2009.03.101.","journal-title":"Biochem Biophys Res Commun"},{"key":"72_CR27","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.bbrc.2007.04.175","volume":"358","author":"M Wakui","year":"2007","unstructured":"Wakui M, Nakano K, Matsushita S: Notch ligand mRNA levels of human APCs predict Th1\/Th2-promoting activities. Biochem Biophys Res Commun. 2007, 358: 596-601. 10.1016\/j.bbrc.2007.04.175.","journal-title":"Biochem Biophys Res Commun"},{"key":"72_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10875-007-9111-1","volume":"27","author":"C Guo","year":"2007","unstructured":"Guo C, Chu X, Shi Y, He W, Li L, Wang L, Wang Y, Peng J, Hou M: Correction of Th1-dominant cytokine profiles by highdose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura. J Clin Immunol. 2007, 27: 557-562. 10.1007\/s10875-007-9111-1.","journal-title":"J Clin Immunol"},{"key":"72_CR29","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1365-2141.2008.07520.x","volume":"144","author":"NN Shan","year":"2009","unstructured":"Shan NN, Zhu XJ, Peng J, Qin P, Zhuang XW, Wang HC, Hou M: Interleukin 18 and interleukin 18 binding protein in patients with idiopathic thrombocytopenic purpura. Br J Haematol. 2009, 144: 755-761. 10.1111\/j.1365-2141.2008.07520.x.","journal-title":"Br J Haematol"},{"key":"72_CR30","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3324\/haematol.2009.007708","volume":"94","author":"NN Shan","year":"2009","unstructured":"Shan NN, Zhu XJ, Wang Q, Wang CY, Qin P, Peng J, Hou M: High dose Dexamethasone regulates interleukin-18 and interleukin-18 binding protein in idiopathic thrombocytopenic purpura. Haematologica. 2009, 94: 1603-1607. 10.3324\/haematol.2009.007708.","journal-title":"Haematologica"},{"key":"72_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00277-009-0790-y","volume":"89","author":"D Ma","year":"2010","unstructured":"Ma D, Dai J, Zhu X, Yan S, Zhao P, Zhang J, Zhu Y, Sun J, Peng J, Ji C, Hou M: Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. Ann Hematol. 2010, 89: 155-161. 10.1007\/s00277-009-0790-y.","journal-title":"Ann Hematol"},{"key":"72_CR32","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3324\/haematol.2009.007823","volume":"94","author":"J Zhang","year":"2009","unstructured":"Zhang J, Ma D, Zhu X, Qu X, Ji C, Hou M: Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura. Haematologica. 2009, 94: 1326-1329. 10.3324\/haematol.2009.007823.","journal-title":"Haematologica"},{"key":"72_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10875-009-9353-1","volume":"30","author":"X Zhu","year":"2010","unstructured":"Zhu X, Ma D, Zhang J, Peng J, Qu X, Ji C, Hou M: Elevated interleukin-21 correlated to Th17 and Th1 cells in patients with immune thrombocytopenia. J Clin Immunol. 2010, 30: 253-259. 10.1007\/s10875-009-9353-1.","journal-title":"J Clin Immunol"},{"key":"72_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1756-8722-6-28","volume":"12","author":"AM Rocha","year":"2013","unstructured":"Rocha AM, Souza C, Rocha GA, de Melo FF, Clementino NC, Marino MC, Queiroz DM: The serum levels of the cytokines involved in the Th17 and Th1 cell commitment are increased in individuals with borderline thrombocytopenia. J Hematol Oncol. 2013, 12: 28-10.1186\/1756-8722-6-28.","journal-title":"J Hematol Oncol"},{"key":"72_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2141.2011.08614.x","volume":"153","author":"XG Liu","year":"2011","unstructured":"Liu XG, Ren J, Yu Y, Sun L, Shi Y, Qin P, Yang L, Ma SH, Dong XY, Ma DX, Qu X, Guo CS, Chen CY, Hou M, Peng J: Decreased expression of interleukin-27 in immune thrombocytopenia. Br J Haematol. 2011, 153: 259-267. 10.1111\/j.1365-2141.2011.08614.x.","journal-title":"Br J Haematol"},{"key":"72_CR36","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00277-008-0535-3","volume":"87","author":"D Ma","year":"2008","unstructured":"Ma D, Zhu X, Zhao P, Zhao C, Li X, Zhu Y, Li L, Sun J, Peng J, Ji C, Hou M: Profile of Th17 cytokines (IL-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura. Ann Hematol. 2008, 87: 899-904. 10.1007\/s00277-008-0535-3.","journal-title":"Ann Hematol"},{"key":"72_CR37","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbrc.2007.06.046","volume":"360","author":"M Kamachi","year":"2007","unstructured":"Kamachi M, Aramaki T, Tanimura S, Ichinose K, Fujikawa K, Iwamoto N, Yoshizaki A, Ida H, Kawakami A, Kohno M, Eguchi K: Activation of protein phosphatase causes alternative splicing of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): potential effect on immune surveillance. Biochem Biophys Res Commun. 2007, 360: 280-285. 10.1016\/j.bbrc.2007.06.046.","journal-title":"Biochem Biophys Res Commun"},{"key":"72_CR38","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.exphem.2004.07.022","volume":"32","author":"SA Crist","year":"2004","unstructured":"Crist SA, Elzey BD, Ludwig AT, Griffith TS, Staack JB, Lentz SR, Ratliff TL: Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets. Exp Hematol. 2004, 32: 1073-1081. 10.1016\/j.exphem.2004.07.022.","journal-title":"Exp Hematol"},{"key":"72_CR39","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1002\/eji.1830251120","volume":"25","author":"MC Filion","year":"1995","unstructured":"Filion MC, Bradley AJ, Devine DV, D\u00e9cary F, Chartrand P: Autoreactive T cells in healthy individuals show tolerance in vitro with characteristics similar to but distinct from clonal anergy. Eur J Immunol. 1995, 25: 3123-3127. 10.1002\/eji.1830251120.","journal-title":"Eur J Immunol"},{"key":"72_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bbrc.2004.12.004","volume":"327","author":"H Kaneda","year":"2005","unstructured":"Kaneda H, Takeda K, Ota T, Kaduka Y, Akiba H, Ikarashi Y, Wakasugi H, Kronenberg M, Kinoshita K, Yagita H, Okumura K: ICOS costimulates invariant NK T cell activation. Biochem Biophys Res Commun. 2005, 327: 201-207. 10.1016\/j.bbrc.2004.12.004.","journal-title":"Biochem Biophys Res Commun"},{"key":"72_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.imlet.2006.02.007","volume":"105","author":"ME van Berkel","year":"2006","unstructured":"van Berkel ME, Oosterwegel MA: CD28 and ICOS: similar or separate costimulators of T cells?. Immunol Lett. 2006, 105: 115-122. 10.1016\/j.imlet.2006.02.007.","journal-title":"Immunol Lett"},{"key":"72_CR42","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bbrc.2003.09.065","volume":"310","author":"N Okamoto","year":"2003","unstructured":"Okamoto N, Tezuka K, Kato M, Abe R, Tsuji T: PI3-kinase and MAP-kinase signaling cascades in AILIM\/ICOS- and CD28-costimulated T-cells have distinct functions between cell proliferation and IL-10 production. Biochem Biophys Res Commun. 2003, 310: 691-702. 10.1016\/j.bbrc.2003.09.065.","journal-title":"Biochem Biophys Res Commun"},{"key":"72_CR43","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.1182\/blood-2009-05-217513","volume":"114","author":"XJ Zhu","year":"2009","unstructured":"Zhu XJ, Shi Y, Peng J, Guo CS, Shan NN, Qin P, Ji XB, Hou M: The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. Blood. 2009, 114: 5362-5367. 10.1182\/blood-2009-05-217513.","journal-title":"Blood"},{"key":"72_CR44","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/16717","volume":"397","author":"A Hutloff","year":"1999","unstructured":"Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, Kroczek RA: ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 1999, 397: 263-266. 10.1038\/16717.","journal-title":"Nature"},{"key":"72_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/35051100","volume":"409","author":"C Dong","year":"2001","unstructured":"Dong C, Juedes AE, Temann UA, Shresta S, Allison JP, Ruddle NH, Flavell RA: ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature. 2001, 409: 97-101. 10.1038\/35051100.","journal-title":"Nature"},{"key":"72_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1756-8722-6-33","volume":"9","author":"CJ Shen","year":"2013","unstructured":"Shen CJ, Yang YX, Han EQ, Cao N, Wang YF, Wang Y, Zhao YY, Zhao LM, Cui J, Gupta P, Wong AJ, Han SY: Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma. J Hematol Oncol. 2013, 9: 33-10.1186\/1756-8722-6-33.","journal-title":"J Hematol Oncol"},{"key":"72_CR47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1517\/14728222.6.3.275","volume":"6","author":"RW Stuart","year":"2002","unstructured":"Stuart RW, Racke MK: Targeting T cell costimulation in autoimmune disease. Expert Opin Ther Targets. 2002, 6: 275-289. 10.1517\/14728222.6.3.275.","journal-title":"Expert Opin Ther Targets"},{"key":"72_CR48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1074-7613(00)00011-X","volume":"13","author":"AJ Coyle","year":"2000","unstructured":"Coyle AJ, Lehar S, Lloyd C, Tian J, Delaney T, Manning S, Nguyen T, Burwell T, Schneider H, Gonzalo JA, Gosselin M, Owen LR, Rudd CE, Gutierrez-Ramos JC: The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity. 2000, 13: 95-105. 10.1016\/S1074-7613(00)00011-X.","journal-title":"Immunity"},{"key":"72_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0167-5699(00)01665-0","volume":"21","author":"L Stoltze","year":"2000","unstructured":"Stoltze L, Nussbaum AK, Sijts A, Emmerich NP, Kloetzel PM, Schild H: The function of the proteasome system in MHC class I antigen processing. Immunol Today. 2000, 21: 317-319. 10.1016\/S0167-5699(00)01665-0.","journal-title":"Immunol Today"},{"key":"72_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2776(02)80012-8","volume":"80","author":"KL Rock","year":"2002","unstructured":"Rock KL, York IA, Saric T, Goldberg AL: Protein degradation and the generation of MHC class I-presented peptides. Adv Immunol. 2002, 80: 1-70. 10.1016\/S0065-2776(02)80012-8.","journal-title":"Adv Immunol"},{"key":"72_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ni.2785","volume":"15","author":"S Gerondakis","year":"2014","unstructured":"Gerondakis S, Fulford TS, Messina NL, Grumont RJ: NF-\u03baB control of T cell development. Nat Immunol. 2014, 15: 15-25. 10.1038\/ni.2785.","journal-title":"Nat Immunol"},{"key":"72_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2010.09.005","volume":"135","author":"L Tuosto","year":"2011","unstructured":"Tuosto L: NF-\u03baB family of transcription factors: biochemical players of CD28 co-stimulation. Immunol Lett. 2011, 135: 1-9. 10.1016\/j.imlet.2010.09.005. 30","journal-title":"Immunol Lett"},{"key":"72_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12026-011-8216-z","volume":"50","author":"J Cheng","year":"2011","unstructured":"Cheng J, Montecalvo A, Kane LP: Regulation of NF-\u03baB induction by TCR\/CD28. Immunol Res. 2011, 50: 113-117. 10.1007\/s12026-011-8216-z.","journal-title":"Immunol Res"},{"key":"72_CR54","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.2174\/1381612811319060004","volume":"19","author":"E Jankowska","year":"2013","unstructured":"Jankowska E, Stoj J, Karpowicz P, Osmulski PA, Gaczynska M: The proteasome in health and disease. Curr Pharm Des. 2013, 19: 1010-1028. 10.2174\/1381612811319060004.","journal-title":"Curr Pharm Des"},{"key":"72_CR55","first-page":"5","volume":"S5","author":"ST Pellom Jr","year":"2012","unstructured":"Pellom ST, Shanker A: Development of Proteasome Inhibitors as Therapeutic Drugs. J Clin Cell Immunol. 2012, S5: 5-","journal-title":"J Clin Cell Immunol"},{"key":"72_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1756-8722-4-16","volume":"20","author":"Y Yuan","year":"2011","unstructured":"Yuan Y, Liao YM, Hsueh CT, Mirshahidi HR: Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP. J Hematol Oncol. 2011, 20: 16-10.1186\/1756-8722-4-16.","journal-title":"J Hematol Oncol"},{"key":"72_CR57","first-page":"1818","volume":"68","author":"Y Saeki","year":"2010","unstructured":"Saeki Y, Fukunaga K, Tanaka K: Proteasome inhibitors. Nihon Rinsho. 2010, 68: 1818-1822.","journal-title":"Nihon Rinsho"},{"key":"72_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1756-8722-3-45","volume":"23","author":"PB Johnston","year":"2010","unstructured":"Johnston PB, Yuan R, Cavalli F, Witzig TE: Targeted therapy in lymphoma. J Hematol Oncol. 2010, 23: 45-10.1186\/1756-8722-3-45.","journal-title":"J Hematol Oncol"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-014-0072-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13045-014-0072-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-014-0072-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-014-0072-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T05:47:39Z","timestamp":1630561659000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-014-0072-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,2]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["72"],"URL":"https:\/\/doi.org\/10.1186\/s13045-014-0072-6","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,2]]},"assertion":[{"value":"5 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"72"}}